Writer : Dr. Lilac
Ref : https://wechat.dxy.cn/news/view?noshare=false&watermark=false&nocopy=false&email=false&simuri=%2Fjapi%2Fweixin%2Fnews%2F43482%2FlYgwWZvszpZOQ%2Fdata&teamId=222
English Translation by : Gan Yung Chyan
/ KUCINTA SETIA
On 18 February 2020, the General Office of the National Health Commission and the Office of the State Administration of Traditional Chinese Medicine in mainland China has jointly released a COVID-19 diagnosis and treatment plan (the sixth edition).
Compared with the commonly used fifth edition, the sixth edition of the diagnosis and treatment plan has the following notable changes:
The transmission route added "there is a possibility of aerosol transmission in a relatively closed environment when exposed to high concentrations of aerosol for a long time." It is affirmed that there is aerosol transmission, but the limited conditions are mainly necessary to consider high concentration conditions in hospitals.
The diagnostic criteria are no longer divided into Hubei and outside Hubei. The diagnosis is divided into suspected cases and confirmed cases. The confirmed cases still require positive evidence of viral nucleic acid testing or homologous gene sequencing. The clinical diagnosis cases specifically for Hubei have been cancelled. Therefore, the number of reported diagnosed covid cases in Hubei have decreased recently.
Imaging criteria have been added to the diagnostic criteria for critically ill patients. Pulmonary imaging examinations with significant lesion progression of more than 50 per cent within 24-48 hours should also be included in intensive care.
A clear course of treatment for 10 days by antiviral therapy is recommended, and recommendations for chloroquine phosphate and abidol were added. It is emphasized that this is a cure, not prevention. Although chloroquine phosphate is clinically considered effective, it has no special effect. It is still necessary to further verify its efficacy and safety, and not to be blindly abused. Emphasize the need to avoid the combined use of broad-spectrum antimicrobials.
There are no changes in discharge criteria, and the four criteria are still normal temperature for 3 days, significant improvement in respiratory symptoms, improved imaging, and negative nucleic acid for 2 consecutive days. At the same time, post-hospital precautions are recommended, as there is still a risk of virus transmission at discharge, which requires another 14 days of continued health monitoring and medical observation.
StayGate's Notes:
As of 19 February 2020, Hubei has 61682 confirmed cases of COVID-19 while outside Hubei in mainland China there are 10728 confirmed cases of the contagious disease. Ranking second in confirmed cases is Guangdong with 1331 cases, followed by Henan with 1262 cases, Zhejiang with 1174 cases, Hunan with 1008 cases, Anhui with 986 cases, Jiangsu with 631 cases, Jiangxi with 571 cases, Chongqing with 555 cases, Shandong with 544 cases, Beijing with 393 cases, Heilongjiang with 341 cases, Shanghai with 333 cases, Hebei with 306 cases, Guangxi with 244 cases, Shanxi with 242 cases, Fujian with 188 cases, Hainan with 163 cases, Guizhou with 146 cases, Liaoning with 121 cases, Ningxia with 71 cases, Inner Mongolia with 66 cases and Jilin with 52 cases. These numbers are subject to changes from day to day.
Ref : https://ncov.dxy.cn/ncovh5/view/pneumonia
Ref : https://wechat.dxy.cn/news/view?noshare=false&watermark=false&nocopy=false&email=false&simuri=%2Fjapi%2Fweixin%2Fnews%2F43482%2FlYgwWZvszpZOQ%2Fdata&teamId=222
English Translation by : Gan Yung Chyan
/ KUCINTA SETIA
On 18 February 2020, the General Office of the National Health Commission and the Office of the State Administration of Traditional Chinese Medicine in mainland China has jointly released a COVID-19 diagnosis and treatment plan (the sixth edition).
Compared with the commonly used fifth edition, the sixth edition of the diagnosis and treatment plan has the following notable changes:
The transmission route added "there is a possibility of aerosol transmission in a relatively closed environment when exposed to high concentrations of aerosol for a long time." It is affirmed that there is aerosol transmission, but the limited conditions are mainly necessary to consider high concentration conditions in hospitals.
The diagnostic criteria are no longer divided into Hubei and outside Hubei. The diagnosis is divided into suspected cases and confirmed cases. The confirmed cases still require positive evidence of viral nucleic acid testing or homologous gene sequencing. The clinical diagnosis cases specifically for Hubei have been cancelled. Therefore, the number of reported diagnosed covid cases in Hubei have decreased recently.
Imaging criteria have been added to the diagnostic criteria for critically ill patients. Pulmonary imaging examinations with significant lesion progression of more than 50 per cent within 24-48 hours should also be included in intensive care.
A clear course of treatment for 10 days by antiviral therapy is recommended, and recommendations for chloroquine phosphate and abidol were added. It is emphasized that this is a cure, not prevention. Although chloroquine phosphate is clinically considered effective, it has no special effect. It is still necessary to further verify its efficacy and safety, and not to be blindly abused. Emphasize the need to avoid the combined use of broad-spectrum antimicrobials.
There are no changes in discharge criteria, and the four criteria are still normal temperature for 3 days, significant improvement in respiratory symptoms, improved imaging, and negative nucleic acid for 2 consecutive days. At the same time, post-hospital precautions are recommended, as there is still a risk of virus transmission at discharge, which requires another 14 days of continued health monitoring and medical observation.
StayGate's Notes:
As of 19 February 2020, Hubei has 61682 confirmed cases of COVID-19 while outside Hubei in mainland China there are 10728 confirmed cases of the contagious disease. Ranking second in confirmed cases is Guangdong with 1331 cases, followed by Henan with 1262 cases, Zhejiang with 1174 cases, Hunan with 1008 cases, Anhui with 986 cases, Jiangsu with 631 cases, Jiangxi with 571 cases, Chongqing with 555 cases, Shandong with 544 cases, Beijing with 393 cases, Heilongjiang with 341 cases, Shanghai with 333 cases, Hebei with 306 cases, Guangxi with 244 cases, Shanxi with 242 cases, Fujian with 188 cases, Hainan with 163 cases, Guizhou with 146 cases, Liaoning with 121 cases, Ningxia with 71 cases, Inner Mongolia with 66 cases and Jilin with 52 cases. These numbers are subject to changes from day to day.
Ref : https://ncov.dxy.cn/ncovh5/view/pneumonia
No comments:
Post a Comment